Discover 329 paid clinical trials in New Mexico. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
New Mexico provides a wide selection of paid research opportunities for both healthy volunteers and individuals with specific health conditions. Leading research sites in Albuquerque, Santa Fe, and Las Cruces are actively recruiting, offering early access to innovative treatments and exceptional healthcare.
Filter
1
Filter results
Results: 329
Active & Responsive
Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Prior Pneumococcal Vaccination
for
Pneumococcal Vaccines
Location: Waterbury CT, Newport News VA, Wilmington NC,
Sponsor: Vaxcyte, Inc.
Sex: All
Age: 50+
Code: NCT07425392
Phase3, Recruiting
Active & Responsive
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
for
Migraine
Location: Boston MA, Waltham MA, Cumberland RI,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT06417775
Phase3, Recruiting
Active & Responsive
A Study of RSLV-132 in Females With Sjögren's Disease
for
Primary Sjögren Syndrome
Location: Boston MA, Boynton Beach FL, Boca Raton FL,
Sponsor: Resolve Therapeutics
Sex: Female
Age: 18 - 70+
Code: NCT06440525
Phase2, Recruiting
Active & Responsive
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
for
Diabetic Peripheral Neuropathic Pain
Location: Boston MA, Waltham MA, East Greenwich RI, New York NY,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 70+
Code: NCT06628908
Phase3, Recruiting
Active & Responsive
RA-PRO PRAGMATIC TRIAL
for
Rheumatoid Arthritis
Location: Boston MA, Worcester MA, New York NY, Exton PA,
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18+
Code: NCT04692493
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Clinical Trial Exploring the Outpatient Treatment of Phantom Limb Pain With Ketamine Administration in a Six Month Study With a Minimum Remission Period of 7 Days Between Treatment Session. 25-30 Subjects With an Ongoing History of Significant PLP.--FDA and IRB Approved.
for
Phantom Limb Syndrome With Pain
Location: Albuquerque NM, Santa Monica CA, Sacramento CA,
Sponsor: The Ketamine Research Foundation
Sex: All
Age: 18 - 65
Code: NCT07276542
Phase2, Phase3, Recruiting
Active & Responsive
Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence
for
Urgency Urinary Incontinence
Location: Providence RI, Washington D.C. DC, Birmingham AL,
Sponsor: Women and Infants Hospital of Rhode Island